The effects of different lignans and isoflavones, tested as aglycones and glycosides, on hormone receptor-positive and -negative breast carcinoma cells in vitro
- 250 Downloads
Phytooestrogens are known to cause anti-cancer effects on mamma carcinoma cells. In this study, the effects of the lignan secoisolariciresinol and the isoflavone glycosides and aglycones genistein, genistin, daidzein and daidzin were tested on MCF-7 and BT20 cells in vitro.
First, the cellular expression of hormone receptors was examined by immunohistochemical procedures. The effects of the phytooestrogens on the cells were detected by using three different assays measuring cell letality, viability and proliferation. The phytooestrogens were tested in concentrations of 1, 5, 10 and 50 μg/mL, respectively. 17β-oestradiol and tamoxifen were used as controls, respectively, in the same concentrations as the phytooestrogens.
The immunohistochemistry showed evidence of oestrogen- and progesterone receptors at the MCF-7 cell line, whereas no expression could be seen at the BT20 cells. Among the phytooestrogens, genistein and secoisolariciresinol showed various anti-cancerogenic effects on both cell lines, respectively, but only in the highest concentration. Regarding the controls, tamoxifen showed a stronger antivital and anti-proliferative effect on BT20 than on MCF-7. Oestradiol caused sporadic anti-cancer effects on both cell lines, respectively, at its highest concentration.
Genistein and Secoisolariciresinol have anti-cancer properties on MCF-7 and BT20 in vitro. There are differences in the effects of isoflavones depending on the glycolysation status. The role of the oestrogen receptors in the mechanisms of action of both the phytooestrogens and controls is of less importance. Further investigations have to be carried out, especially concerning the mechanisms of action. Phytooestrogens may be potential substances in the therapy of mamma carcinomas.
KeywordsPhytooestrogens Isoflavones Lignans Secoisolariciresinol Genistein Genistin Daidzein Daidzin Breast cancer MCF-7 BT20
The authors thank Mrs. E. Greschkowitz for technical assistance.
Conflict of interest
We declare that we have no conflict of interest.
- 13.Chen WF, Huang MH, Tzang CH, Yang M, Wong MS (2003) Inhibitory actions of genistein in human breast cancer (MCF-7) cells. Biochim Biophy Acta 1638(2):187–196Google Scholar
- 19.Shao ZM, Shen ZZ, Fontana JA, Barsky SH (2000) Genistein’s “ER-dependent and independent” actions are mediated through ER pathways in ER-positive breast carcinoma cell lines. Anticancer Res 20(4):1–2409Google Scholar
- 32.Boyan BD, Sylvia VL, Frambach T, Lohmann CH, Dietl J, Dean DD, Schwartz Z (2003) Estrogen-dependent rapid activation of protein kinase C in estrogenreceptor positive MCF-7 breast cancer cells and in estrogen-receptor negative HCC38 cells is membrane-mediated and inhibited be tamoxifen. Endocrinology 144(5):1812–1824PubMedCrossRefGoogle Scholar